Patriot Financial Group Insurance Agency, LLC - CRISPR THERAPEUTICS AG ownership

CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 443 filers reported holding CRISPR THERAPEUTICS AG in Q4 2021. The put-call ratio across all filers is 1.13 and the average weighting 0.2%.

Quarter-by-quarter ownership
Patriot Financial Group Insurance Agency, LLC ownership history of CRISPR THERAPEUTICS AG
ValueSharesWeighting
Q3 2023$1,225,394
-17.7%
26,997
+1.7%
0.25%
-10.0%
Q2 2023$1,489,675
+28.2%
26,535
+3.3%
0.28%
+19.1%
Q1 2023$1,161,687
+112.3%
25,684
+90.8%
0.24%
+218.9%
Q4 2022$547,068
-34.4%
13,458
+5.5%
0.07%
-63.5%
Q3 2022$834,000
+211.2%
12,756
+189.5%
0.20%
+275.9%
Q2 2022$268,000
+90.1%
4,406
+95.9%
0.05%
+116.0%
Q1 2022$141,000
+50.0%
2,249
+81.7%
0.02%
+56.2%
Q4 2021$94,000
-21.0%
1,238
+16.8%
0.02%
-23.8%
Q3 2021$119,000
-30.8%
1,0600.0%0.02%
-32.3%
Q2 2021$172,000
+29.3%
1,060
-2.8%
0.03%
+3.3%
Q1 2021$133,000
+0.8%
1,090
+26.9%
0.03%
-9.1%
Q4 2020$132,000
+26.9%
859
-30.7%
0.03%
-2.9%
Q3 2020$104,000
-91.4%
1,239
-92.5%
0.03%
-92.7%
Q2 2020$1,212,000
+42.1%
16,492
-18.0%
0.46%
+19.0%
Q1 2020$853,000
-26.9%
20,105
+4.9%
0.39%
-11.0%
Q4 2019$1,167,000
+37.0%
19,160
-7.8%
0.44%
+14.4%
Q3 2019$852,000
-26.3%
20,780
-15.7%
0.38%
-23.2%
Q2 2019$1,156,000
+40.1%
24,644
+6.7%
0.50%
+18.0%
Q1 2019$825,000
+2.9%
23,086
-17.8%
0.42%
-19.9%
Q4 2018$802,000
+2067.6%
28,072
+3302.7%
0.53%
+2300.0%
Q3 2018$37,000
-97.5%
825
-97.6%
0.02%
-98.0%
Q1 2018$1,476,000
+1062.2%
34,107
+597.5%
1.09%
+1049.5%
Q4 2017$127,0004,8900.10%
Other shareholders
CRISPR THERAPEUTICS AG shareholders Q4 2021
NameSharesValueWeighting ↓
Versant Venture Management, LLC 498,558$27,989,04633.20%
Gilfoyle Management LLC 100$4,84215.90%
NEA Management Company, LLC 1,587,854$89,142,1246.80%
ARK Investment Management 7,338,447$411,980,3942.73%
Nikko Asset Management Americas, Inc. 3,533,357$198,327,3282.09%
Del-Sette Capital Management, LLC 33,661$1,889,7291.79%
Ikarian Capital, LLC 200,000$11,228,0001.79%
Ikarian Capital, LLC 200,000$11,228,0001.79%
Merlin Capital, Inc 8,802$494,1441.67%
Green Alpha Advisors, LLC 34,373$1,929,7001.27%
View complete list of CRISPR THERAPEUTICS AG shareholders